These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6533969)

  • 21. [Clinical aspects of biocompatibility].
    Schiffl H; Lang SM; Keuneke C; Fricke H
    Wien Klin Wochenschr; 1996; 108 Suppl 1():4-8. PubMed ID: 8686323
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical evaluation of the new, steam-sterilized polysulfone high-flux dialyzer.
    Schaefer RM; Kulzer P; Gilge U; Schaefer L; Heidland A
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S21-5. PubMed ID: 7923978
    [No Abstract]   [Full Text] [Related]  

  • 23. Dialysis, neutropenia, lung dysfunction and complement.
    Chervenick PA
    N Engl J Med; 1977 Apr; 296(14):810-2. PubMed ID: 840280
    [No Abstract]   [Full Text] [Related]  

  • 24. Extracorporeal thromboxane release and the morphological structure of artificial membrane after blood exposure.
    Mahiout A; Lajous-Peter AM; Jörres A; Meinhold H; Kessel M
    Kidney Int Suppl; 1988 Mar; 24():S75-9. PubMed ID: 3163057
    [No Abstract]   [Full Text] [Related]  

  • 25. Complement activation as index of haemodialysis membrane biocompatibility: the choice of methods and assays.
    Cheung AK
    Nephrol Dial Transplant; 1994; 9 Suppl 2():96-103. PubMed ID: 8065623
    [No Abstract]   [Full Text] [Related]  

  • 26. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cardiopulmonary manifestations of blood-dialyzer (new and reused) interactions in an animal model.
    Lindsay RM; Walker JF
    Trans Am Soc Artif Intern Organs; 1984; 30():711-4. PubMed ID: 6533968
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hypergranulocytosis. Neutropenia].
    Philippe G; Meier F
    Soins; 1985 Jun; (456):23-6. PubMed ID: 3849897
    [No Abstract]   [Full Text] [Related]  

  • 29. Phosphate removal during dialysis--does the membrane matter?
    Ritz E
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S57-60. PubMed ID: 7923986
    [No Abstract]   [Full Text] [Related]  

  • 30. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
    de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
    Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
    Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
    Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
    [No Abstract]   [Full Text] [Related]  

  • 32. The aetiology of neutropenia in healthy Africans.
    Ezeilo GC
    East Afr Med J; 1974 Dec; 51(12):936-42. PubMed ID: 4455493
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of primary splenic neutropenia].
    Markiewicz K; Dryjański T; Zach E
    Pol Tyg Lek; 1984 Nov; 39(48):1577-8. PubMed ID: 6522315
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of biocompatible membranes on neutrophil function and metabolism.
    Haag-Weber M; Hörl WH
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S31-6. PubMed ID: 7923981
    [No Abstract]   [Full Text] [Related]  

  • 35. [A case of cyclic neutropenia (author's transl)].
    Tajiri M; Ishida K; Ariyama S; Ariyoshi K; Nakashima K
    Rinsho Ketsueki; 1975 May; 16(5):537-42. PubMed ID: 1172052
    [No Abstract]   [Full Text] [Related]  

  • 36. The hemodialysis membranes: a historical perspective, current state and future prospect.
    Cheung AK; Leypoldt JK
    Semin Nephrol; 1997 May; 17(3):196-213. PubMed ID: 9165649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Severe and prolonged neutropenia at the beginning of disseminated lupus erythematosus].
    Weiller PJ; Lam My S; Patenaude JV; Horschowski N; David M; Mongin M
    Nouv Presse Med; 1982 Mar; 11(11):866. PubMed ID: 7070981
    [No Abstract]   [Full Text] [Related]  

  • 38. Nanoporesize affects complement activation.
    Ferraz N; Nilsson B; Hong J; Karlsson Ott M
    J Biomed Mater Res A; 2008 Dec; 87(3):575-81. PubMed ID: 18186072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
    Szepietowski T; Krajewska M
    Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of biocompatible dialysis membranes in acute renal failure.
    Himmelfarb J; Hakim RM
    Adv Ren Replace Ther; 1997 Apr; 4(2 Suppl 1):72-80. PubMed ID: 9113243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.